Epigenetic activation of a RAS/MYC axis in H3.3K27M-driven cancer
Histone H3 at lysine 27 (H3K27M) is often mutated in cancer but its role in tumour initiation is unclear. Here, the authors generated a transgenic model expressing H3.3K27M from the Fabp7 gene promoter, demonstrating that H3.3K27M can initiate diverse tumorigesis on its own, acting through a RAS/MYC...
Guardado en:
Autores principales: | Sanja Pajovic, Robert Siddaway, Taylor Bridge, Javal Sheth, Patricia Rakopoulos, Byungjin Kim, Scott Ryall, Sameer Agnihotri, Lauren Phillips, Man Yu, Christopher Li, Scott Milos, Palak Patel, Dilakshan Srikanthan, Annie Huang, Cynthia Hawkins |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d2950e03eca24abe9198eff022010cfc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation
por: Ke Li, et al.
Publicado: (2020) -
DNA Methylation Profiling of MYC, SMAD2/3 and DNMT3A in Colorectal Cancer
por: Seyedeh Elham Norollahi, et al.
Publicado: (2021) -
Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer
por: Mauricio S. Caetano, et al.
Publicado: (2018) -
Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells.
por: Damian J Junk, et al.
Publicado: (2013) -
Revisiting G3BP1 as a RasGAP binding protein: sensitization of tumor cells to chemotherapy by the RasGAP 317-326 sequence does not involve G3BP1.
por: Alessandro Annibaldi, et al.
Publicado: (2011)